Uppsala, Sweden July 7, 2011 – Biotage® (STO: BIOT), a leading supplier of tools and technology for analytical, medicinal, and peptide chemistry, announced a new microwave synthesizer with state of the art user interface and industry leading operating range.
The Biotage Initiator+ sets a new standard by delivering new opportunities for chemistry professionals needing to enable difficult reactions or to improve yields on critical reaction steps. The new system which boasts very simple and intuitive software, an integrated computer control system and the largest touch screen interface available, allows the user to drive reactions to as high as 300 C and up to 30 bar pressure.
The new Initiator+ also offers an option for the use of a fiber optic temperature measurement device for in-situ reaction monitoring. The expanded pressure range of up to 30 bars, allows for increased flexibility in the choice of solvents. Low boiling point solvents can now be utilized at higher temperatures and reactions performed at maximum speed to achieve best possible yield with higher pressure.
The Initiator+ was developed as an upgradeable platform with automation options readily available. Connect the SP Wave peptide synthesis module and the Robot Eight kit to perform microwave assisted peptide synthesis with vortex mixing. All Initiator+ users will benefit from a versatile instrument which can perform both traditional Organic Synthesis but also enable new discoveries in Peptide and Peptidomimetics research.
“Biotage is acknowledged as a leader in microwave synthesis thanks in part to the top selling Initiator synthesizer. The new Initiator+ is a major engineering achievement of function and capabilities for global professionals”. says Toshiyuki Yachi, Vice President of Marketing. “Our goal was to collaborate with professionals to deliver a new platform of outstanding performance, flexibility and value. With the Initiator+, we have achieved this goal and believe we will set a new standard for microwave synthesis platforms.”
For more information on the Biotage Initiator+ synthesizer, please email firstname.lastname@example.org or visit www.biotage.com
For further press information at Biotage please contact: Rob Thompson, Director of Marketing, 10430 Harris Oaks Blvd., Suite C, Charlotte, NC USA 28269 Tel: +1 704 654 4847 Fax: +1 704 654 4917 Email: email@example.com
Biotage offers solutions, knowledge and experience in the areas of analytical, medicinal and peptide chemistry. The customers include the world’s top pharmaceutical and biotechnology companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, and has offices in the United States, United Kingdom and Japan. Biotage has 272 employees and had sales of 428.9 MSEK in 2010. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange. Website: www.biotage.com
Biotage Releases Isolera™ Dalton 2000
New ISOLUTE® FILTER+ Plates Prevents UPLC Clogging
Extraction of Oxytocin and Vasopressin from Serum Using EVOLUTE® EXPRESS ABN Prior to LC-MS/MS Analysis
The Role of LogP in Sample Preparation Methods
Biotage Awarded for Most Recognized Evaporator